Genes for streptomycin phosphotransferase and inosamine-Pamidinotransferase from a streptomycin-producing Streptomyces griseus were cloned on a 3.8kb BamHI-SphI fragment in S_j _ lividans using the multicopy cloning vector pIJ702. The nucleotide sequence of this 3.8kb fragment was determined and the coding sequences for the two genes were identified by comparison with the amino-terminal sequences of the two enzymes purified from S. lividans clones.
INTRODUCTION
Actinomycetes are known for their ability to produce many kinds of antibiotics having both industrial and clinical importance. Our research efforts have been aimed at strain improvement, study of antibiotic production mechanisms and relations between antibiotic production and producing-strain resistance. Recent progress in Streptomyces gene manipulation techniques has enabled us to approach these problems on the molecular level.
We have cloned the streptomycin phosphotransferase (SPH) gene (1) from Streptomyces griseus ISP 5236, which confers streptomycin (SM) resistance to Streptomyces lividans 1326, and have identified a negative control system for its expression (2) . Recently, several genes involved in SM biosynthesis have been cloned (3, 4, 5) . Genes involved in streptomycin biosynthesis and its regulation were found to be closely associated with the SPH gene. The results from their restriction endonuclease mapping suggested that our cloned 7.0kb Bqlll fragment contained an amidinotransferase (AT) gene and regulatory genes in addition to the SPH gene. In the present paper we report the localization of the SPH and AT genes and the determination of their nucleotide ©IRLPrai Limited, Oxford, England.
sequences. This information will provide a basis for a better understanding of SM biosynthesis and resistance.
MATERIALS AND METHODS Bacterial strains and plasmids
S_j_ lividans 1326 and the plasmid pIJ702 (6) were kindly supplied by Dr. C. J. Thompson . Plasmid pST141, carrying the SPH gene of S_^ qriseus, has been described previously by Tohyama et al. (1), where Bacillus subtilis NIHJ PCI 219 was used for the SM bioassay. Media, DNA preparation and transformation YEME and R2YE media were used for DNA preparation and transformation as described by Chater et al. (7), a small-scale preparation of plasmid DNA being carried out using the alkaline extraction method (8) .
Assay of SM inactivating activity
A cell-free extract was assayed for SM inactivating activity using the method described by Nimi et al. (9) ; the reaction mixture (50 ^1) contained 100 mM Tris-malate buffer, pH 7.0, 10 mM MgSO 4 , 3 mM ATP, 1 mM SM and 25 pi of cell-free extract. After incubating for 1 hr at 37*C, the mixture was heated to 100'C for 5 min. The remaining SM was assayed using the agar diffusion method, and the protein content was estimated using Bradford's method (10) with bovine serum albumin as standard.
Assay of AT activity
Transamidination from L-arginine to hydroxylamine, which is catalyzed by AT enzyme, was assayed by measuring the formation of hydroxyguanidine according to Walker'3 method III (11) . Nucleotide sequence analysis
The sequencing strategy is shown in Fig. 2 . DNA fragments, cloned into M13 mp18 and mp19, were sequenced by the dideoxy method using [0(-^5S] dATPflS (Amersham Co.) and buffer gradient gel, according to the "M13 cloning and sequencing handbook" from the Amersham Co. (No.4502). The company also supplied the sequencin' materials (Cat. No.4502). Purification of. SPH Spores of S^ lividans, harboring pST141 (see Fig. 1 ), were inoculated into 20 ml of YEME medium and incubated at 27 °C for For measurement of amidinotransferase(AT) specific activity, 100 ml culture in YEME medium was harvested at late log phase, and cell-free extract prepared by sonication. Arrows indicate the SPH and AT genes. three days, and 10 ml of the culture were transferred to 1 1 YEME medium supplemented with 5 ,ug SM/ml and incubated at 27t for three days. The mycelium (6.3 g) was harvested by centrifugation, washed with saline and suspended in 25 ml Tris-malate buffer (100 mM Tris-malate pH 7.0, 10 mM MgSO^). Cell-free extract was obtained by sonication followed by centrifugation (30,000xg_, 30 min). Following ammonium sulfate precipitation (45% saturation), the supernatant was dialyzed against Tris-malate buffer and further purified by SM-affinity column chromatography. A 5 ml SM-affinity column (Pharmacia Co.; epoxy-activated Sepharose 6B) was prepared according to the manufacturer's instructions. The SPH activity was eluted with 5 mM SM. Purification of. AT
The mycelium was grown as for the purification of SPH. The 5.6 g mycelium was resuspended in 23 ml of 50 mM potassium phosphate buffer, pH 7.4, containing 1 mM EDTA and 3 mM mercaptoethanol, and disrupted by sonication. Polyethyleneimine (0.3%) was added to the extract prior to ammonium sulfate precipitation (45% saturation). The supernatant was dialyzed against the above potassium phosphate buffer and subjected to anion-exchange chromatography using a mono-Q column with a 0-1 M NaCl gradient (Pharmacia FPLC system). The AT activity was eluted as a single peak at 420 mM NaCl. Electrophoresia Agarose (0.7%) gel electrophoresis of DNA was carried out in 90 mM Tris-boric acid and 4 mM EDTA buffer, pH 8.3; for the recovery of DNA, low-gel1 ing-temperature agarose (Miles Laboratories, Inc., Elkhart, U.S.A.) was used. Protein analysis was carried out by sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis (SDS-PAGE) using Laemmli's method (12) . The protein in the gel was made visible upon silver staining (13) using a reagent kit from Daiichi Pure Chemicals Co., Tokyo, Japan. SPH enzyme protease cleavage Achromobacter lyticus protease I (14) and Staphylococcus aureua V3 protease (15) were purchased from Wako Chemical Industries, Osaka, Japan and used to cleave SPH. The SPH (15 nmol) was dissolved in 500 pi of 50 mM Tris-HCl (pH9.0) containing 0.1% SDS, and mixed with A^ lyticus protease I (0.15 nmol) which specifically cleaves at the Lys-X sequence. The mixture was maintained at 28 *C for 16 hr, after which it was directly subjected to the reverse-phase FPLC system. For cleavage with £3^ aureus Vg protease, which specifically cleaves protein at the Glu-X sequence at pH 4.0, SPH (15 nmol) was dissolved in 200 pi of 100 mM ammonium-acetate buffer, pH 4.0, containing 10 mM dithiothreitol; the protease (4% of substrate) was added twice, at 0 and 4 hr. The reaction was carried out at 37°C for 16 hr, and the resultant fragments were purified by reverse-phase FPLC. Amino acid sequencing N-terminal sequences were obtained by automated Edman degradation using a gas-phase protein sequenator (Applied Biosystems model 470A). Samples to be sequenced were purified to homogeneity by reverse-phase chromatography in a 0-80% acetonitrile gradient containing 0.1% trifluoroacetic acid (Pharmacia FPLC system: Pro-RPC or Pep-RPC was used as a column.) before application. SPH enzyme amino acid composition SPH (1.5 nmol) was hydrolyzed in a 2:1 solution of cone. HC1: trifluoroacetic acid at 150*C for 1 hr. The hydrolysate was analyzed on a Hitachi 835 amino acid analyzer to determine its amino acid composition.
RESULTS
Subcloning to localize the SPH and AT genes S. lividans 1326, harboring pST141 (1), is SM resistant and shows AT activity (Fig. 1 ) . In order to define the location of the SPH and AT genes, several subclones were constructed from pST141 and tested for SM resistance and AT activity. As shown in Fig. 3 . Hucleotide sequence of the BamHId)-Sph(1 ) fragment containing the SPH and AT genes. Arrows indicate inverted and direct repeat sequences. Underlined amino acid residues were also determined from the protein sequence. The potential ribosome binding sites are boxed.
SPH gene nucleotide sequence and enzyme amino acid sequence
In order to find the precise locations of the SPH and AT genes, the nucleotide sequence of the 3.8kb BamHId)-SphI(3) fragment, which presumably contained both genes, was determined and compared to the partial amino acid sequences of SPH and AT. The nucleotide sequence of the 3830 base is shown in Fig.3 together with the deduced amino acid sequences corresponding to the four open reading frames. The coding sequence for the SPH gene (918bp, 306 a.a., MW 33,148) was identified as starting from ATG at 1 043 and terminating with TGA at 1 964, and that for the AT gene (1038bp, 346 a.a., MW 38,828) from ATG at 2456 to TGA at 3497, by assigning the amino acid sequences predicted from the nucleotide sequences to those of the purified enzymes. (The initiating methionine residues of both enzymes were processed.) The two amino acid sequences starting at 3 and 3683, shown in Fig. 3 , have been predicted from the nucleotide sequence.
The molecular weight of SPH was estimated to be approximately 35,000 by SDS-PAGE. The N-terminal amino acid sequences of four peptide fragments, obtained from the SPH enzyme upon treatment with A^ lyticus protease I and S_j _ aureus Vg protease, were identified as peptides corresponding to the amino acid sequence of 1-45, 46-72 and 73-305 and 128-153 (underlined in Fig. 3 ). There was agreement between the araino acid sequence and the nucleotide sequence of SPH, except for one amino acid difference at amino acid number 47 (the nucleotide sequence indicated Asp whereas the amino acid sequence indicated Glu). This result proves SPH to be the product of the cloned gene. The araino acid composition of SPH, and the codon usage of the SPH gene, are shown in Tables 1 and 2 , respectively. The amino acid composition of purified SPH was in good agreement with that predicted from the nucleotide sequence. AT gene nucleotide sequence and enzyme amino acid sequence
We purified the AT enzyme from ^ lividans containing pST141. The molecular weight of the purified AT enzyme was estimated to be approximately 42,000 from SDS-PAGE. The N-terminal amino acid sequence was determined as being Ser-Leu-Val-Ser-Val-His-Asn-GluTrp-Asp-Pro-Leu-Glu-Glu (Fig. 3) , which is identical to the sequence predicted from the DNA sequence. It is clear that the open reading frame, starting from ATG at 2456 and ending with TGA at 3497, is the coding sequence for AT.
DISCUSSION
The nucleotide sequence analysis of the DamHI(1)-SphI(3) fragment (3.8 kb) showed the AT gene to be located in the Sphl(2)-Pstl region, as shown in Figs. 1 and 2 . In a separate experiment (2), the Sphl(2)-PatI region containing the AT gene was defined as a determinant repressing SPH activity. A protein was co-purified with SPH by SM-affinity column chroraatography from a cell-free extract of S_; _ lividans harboring pST141. In the present experiment, this protein, which we had assumed to be a represser, was found to be identical to AT in the N-terminal sequence. A possible explanation for this coincidence could be: 1) that the protein is bifunctional, both catalyzing transamidination and acting as a repressor to the SPH activity induced by SM; 2) that the other trans-acting mechanisms which repress SPH activity, such as anti-sense RNA, might exist within the Sphl(2)-Pstl region containing the AT gene; or 3) that the AT enzyme, or its product, modifies the SPH gene expression or the SPH enzyme itself. The absolute answer cannot be deduced from the nucleotide sequence, and further experiments are necessary. Two inverted repeat sequences, which are found downstream of the TGA codon of the SPH gene, may act as signals for transcription termination. The transcription termination of the S. hygroscoplcus hygB gene occurred 5' of two inverted repeat sequence structures (17) . Similar structures were reported in other Streptomvces genes sequenced so far (18, 19) . The structure, however, seems not to be present in the 3 1 region of the AT gene.
Two possible ribosome binding sites, which can interact with the 3' terminal of the 16S rRNA from S. livldans (20) , are found 8 bp and 2 bp preceding the ATG codon of the SPH and AT genes, respectively.
The high G+C contents of the third position of the codon (Table 2) in both the SPH and AT genes (89% and 95%, respectively) are similar to those in other Streptomyces genes (21) . According to the above rule, the two putative coding sequences are found, one, upstream of the SPH gene and, the other, downstream of the AT gene (the G+C contents at the third position of these open reading frames are 90% and 98%, respectively). One of them starts upstream of the SphI(3) site, ends with TGA at 438, and is followed by an inverted repeat sequence which may form a secondary -structure for transcription termination. The putative coding sequence may be a part of the regulatory gene (strR) which has been reported by Ohnuki et al. (3) or the biosynthesis gene reported by Distler et al. (4) . Another putative coding sequence starts from ATG at 3683. In the 5" region of the sequence, three direct repeats (CCGGGCA) (shown by arrows in Fig. 3) , an inverted repeat (CACCGGGC) (shown by arrows in Fig. 3 ) and a sequence (TACAAC), similar to the -10 consensus sequence (TATAAT) of the E.coll promoter, are found. Recently, Kumada et al. (5) reported the cloning of a SM biosynthesis gene directing a step in the N-methyl-L-glucosamine pathway from S^ bikiniensis IFO 13350 (ISP 5235), which is known to be taxonomically identical to the S^ griseus ISP 5236 (22) used for cloning the SPH gene. Their restriction map for the cloned DNA fragment is essentially identical to our cloned DNA in the BqlII(1 )-PstI region, and they claimed the SphI site(s) to be essential for expression of the gene. These facts strongly suggest that the putative coding sequence starting from ATG at 3683, which contained the Sphl(2) site, is that for the gene reported by Kumada et al. (5) .
The SPH activity is induced by SM (2) or A-factor (23); furthermore, both SPH and AT activities are stimulated by the strR gene (3) . Accordingly, it is of interest to clarify the relation between the stimulative activity of SM, the A-factor and the strR gene in terms of SPH activity. If the control system(s) for the expression of the SPH and AT genes is mediated by a repressor(s) and/or an activator(s), the recognition sequence(s) of the regulatory protein can be identified. The inverted repeat sequence, CATGTGTAA, is found at 1023 in the 5 1 region of the SPH gene, GCGGACCGC and CGGGGCCGC are found at 2333 and at 2389 in the 5 1 region of the AT gene, and GGGCACCGGG is also found at 3618 in the 5' region of the putative coding sequence, although no similarities exist among them. These inverted repeat sequences may explain the complicated expression of the genes relating to SM biosynthesis and resistance.
It is of further interest that an inverted repeat sequence (GTTCGACTGC) found at 251 in the putative coding sequence is also found at 2048 in the 3' region of the SPH gene. Moreover, overlapping inverted repeat sequences, which are similar to those found in the attenuator system of E;_ coli trp operon (24) , or to those found in the erythromycin-induced resistance mechanism of Staphylococcus aureus (25) , are found in the coding region of the AT gene (GCGGTGGG and CCACCGCGGA).
